Patients with hypertension, diabetes, and obesity frequently use glucagon-like peptide-1 receptor (GLP-1R) agonists, angiotensin receptor blockers (ARBs), and ACE inhibitors (ACEIs). The gene discussed is GLP1R; the disease is hypertensive disorder.